title: The EBCTCG overview of adjuvant therapy of breast cancer. What are the implications for future studies? Early Breast Cancer Trialists' Collaborative Group.
authors.affiliation: ICRF/MRC Clinical Trial Service Unit, Radcliffe Infirmary, Oxford, United Kingdom.
authors.forename: R
authors.initials: R
authors.lastname: Gray
authors.forename: M
authors.initials: M
authors.lastname: Clarke
authors.forename: R
authors.initials: R
authors.lastname: Collins
authors.forename: R
authors.initials: R
authors.lastname: Peto
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D003520:Cyclophosphamide / Q000008:administration & dosage; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D008727:Methotrexate / Q000008:administration & dosage; D008875:Middle Aged; D010052:Ovariectomy; D017698:Postmenopause; D017697:Premenopause; D012189:Retrospective Studies; D013629:Tamoxifen / Q000627:therapeutic use*
chemical_list: D013629:Tamoxifen; D003520:Cyclophosphamide; D005472:Fluorouracil; D008727:Methotrexate